Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Experiment-model interaction for analysis of epicardial activation during human ventricular fibrillation with global myocardial ischaemia

Clayton RH. et al, (2011), Progress in Biophysics and Molecular Biology, 107, 101 - 111

Experiment-model interaction for analysis of epicardial activation during human ventricular fibrillation with global myocardial ischaemia.

Clayton RH. et al, (2011), Prog Biophys Mol Biol, 107, 101 - 111

Human ventricular fibrillation during global ischemia and reperfusion: paradoxical changes in activation rate and wavefront complexity.

Bradley CP. et al, (2011), Circ Arrhythm Electrophysiol, 4, 684 - 691

In vivo tissue engineering of musculoskeletal tissues.

McCullen SD. et al, (2011), Curr Opin Biotechnol, 22, 715 - 720

Infectious delivery and long-term persistence of transgene expression in the brain by a 135-kb iBAC-FXN genomic DNA expression vector

Gimenez-Cassina A. et al, (2011), Gene Therapy, 18, 1015 - 1019

Infectious delivery and long-term persistence of transgene expression in the brain by a 135-kb iBAC-FXN genomic DNA expression vector.

Gimenez-Cassina A. et al, (2011), Gene Ther, 18, 1015 - 1019

Intervertebral disk nutrition: a review of factors influencing concentrations of nutrients and metabolites.

Grunhagen T. et al, (2011), Orthop Clin North Am, 42, 465 - vii

Intranasal Exosomes for Treatment of Neuroinflammation?: Prospects and Limitations.

Lakhal S. and Wood MJ., (2011), Mol Ther, 19, 1754 - 1756

Intranasal exosomes for treatment of neuroinflammation? Prospects and limitations.

Lakhal S. and Wood MJ., (2011), Mol Ther, 19, 1754 - 1756

Intravenous iron and pulmonary hypertension in intensive care

Smith TG. et al, (2011), Intensive Care Medicine, 37

Intravenous iron and pulmonary hypertension in intensive care.

Smith TG. et al, (2011), Intensive Care Med, 37

LEPIGENETIC MYOSTATIN BLOCKADE

Roberts T. et al, (2011), NUCLEIC ACID THERAPEUTICS, 21, A24 - A24

Local termination of 3'-5'-cyclic adenosine monophosphate signals: the role of A kinase anchoring protein-tethered phosphodiesterases.

Stangherlin A. and Zaccolo M., (2011), J Cardiovasc Pharmacol, 58, 345 - 353

Measurement and meaning of markers of reactive species of oxygen, nitrogen and sulfur in healthy human subjects and patients with inflammatory joint disease.

Winyard PG. et al, (2011), Biochem Soc Trans, 39, 1226 - 1232

Microscopy to mechanism across the scales of development.

Megason SG. et al, (2011), Curr Opin Genet Dev, 21, 519 - 522

Minimum Information about a Cardiac Electrophysiology Experiment (MICEE): standardised reporting for model reproducibility, interoperability, and data sharing.

Quinn TA. et al, (2011), Prog Biophys Mol Biol, 107, 4 - 10

Minimum Information about a Cardiac Electrophysiology Experiment (MICEE): Standardised reporting for model reproducibility, interoperability, and data sharing

Quinn TA. et al, (2011), Progress in Biophysics and Molecular Biology, 107, 4 - 10

Model interactions: 'It is the simple, which is so difficult'.

Kohl P. et al, (2011), Prog Biophys Mol Biol, 107, 1 - 3

Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies

Ravenscroft G. et al, (2011), NEUROMUSCULAR DISORDERS, 21, 751 - 751

NOVEL CELL PENETRATING PEPTIDES FOR SKELETAL AND CARDIAC MUSCLE DELIVERY OF PMO ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

Hammond SM. et al, (2011), NUCLEIC ACID THERAPEUTICS, 21, A12 - A12

Load More

«
...
234
235
236
237
238
239
240
...
»

Include forthcoming?